These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33563326)

  • 1. Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report.
    Toyoda J; Morioka D; Horii N; Nakayama G; Oyama N; Asano F; Izumisawa Y; Miura M; Sato Y; Endo I
    J Med Case Rep; 2021 Feb; 15(1):52. PubMed ID: 33563326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
    Tadokoro T; Tani J; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Fujita K; Nomura T; Morishita A; Kobara H; Himoto T; Ono M; Masaki T
    Sci Rep; 2024 May; 14(1):10784. PubMed ID: 38734732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar hemorrhage in patients treated with edoxaban for portal vein thrombosis after hepatobiliary surgery: a report of two cases.
    Iida H; Miyake T; Tani M; Tanaka T; Kawakami K; Ikuno Y; Mandai R; Shimizu T
    Surg Case Rep; 2020 Dec; 6(1):319. PubMed ID: 33305345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dissolution and maintenance of portal vein thrombosis with antithrombin III and edoxaban in liver cirrhosis:a case report].
    Eto H; Kawabe K; Kasai T; Muramatsu S; Miyahara Y; Nakahara M; Fukuda H; Imai T; Ito H
    Nihon Shokakibyo Gakkai Zasshi; 2019; 116(6):523-530. PubMed ID: 31178582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful recanalization of completely obstructed portal vein thrombosis after right hepatectomy for perihilar cholangiocarcinoma by aspiration thrombectomy via the ileocolic mesenteric vein and subsequent systemic anticoagulation with edoxaban.
    Gon H; Tsugawa D; Yanagimoto H; Ueshima E; Mizumoto T; So S; Toyama H; Kido M; Ajiki T; Fukumoto T
    Clin J Gastroenterol; 2022 Oct; 15(5):981-987. PubMed ID: 35768758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
    Nagaoki Y; Aikata H; Daijyo K; Teraoka Y; Shinohara F; Nakamura Y; Hatooka M; Morio K; Nakahara T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2018 Jan; 48(1):51-58. PubMed ID: 28342265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
    Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
    Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis.
    Obata F; Abe H; Murakami T; Ueda S; Inagaki T; Minato M; Ono H; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Nagai K; Doi T
    CEN Case Rep; 2019 May; 8(2):134-138. PubMed ID: 30721455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
    Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
    Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.
    Chen H; Trilok G; Wang F; Qi X; Xiao J; Yang C
    Indian J Med Res; 2014 Feb; 139(2):260-6. PubMed ID: 24718401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlational study on portal vein thrombosis of liver cirrhosis].
    Xu DQ; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Gao Y; Liu H; Tang F; Zhang X; Li F; Ye Q; Yuan H; Lv H; Han T
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101649. PubMed ID: 33601064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Weinberg EM; Palecki J; Reddy KR
    Semin Liver Dis; 2019 May; 39(2):195-208. PubMed ID: 30978730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recanalization of port-superior mesenteric vein thrombosis with long-term anticoagulant therapy after failed early anticoagulant therapy.
    Okada I; Hagiwara M; Yoneyama H; Kohara S; Shoji Y
    Surg Case Rep; 2024 Jun; 10(1):154. PubMed ID: 38900377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.